Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seidl

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|December 1, 1992
Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endotheliumB Watschinger, W Ulrich, A Vychytil, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|May 1, 1975
Representative HL-A phenotype and haplotype frequencies of the german populationE D Albert, S Scholz, J Bertrams, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis]P Kühnl, M Roggendorf, W Sibrowski, et al.
Digestion|March 20, 2008
True adenomas of the cardia: a case series of 3 patientsM Bajbouj, C von Weyhern, V Becker, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study]S Seidl, P Kühnl, J Beyer, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
Abbott HCV EIA 2nd generation: a new screening assayW Weise, U Bäcker, S Seidl, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)]P Kühnl, M Roggendorf, W Stangel, et al.
AIDS (London, England)|December 1, 1988
A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteinsU Bäcker, A Gathof, J Howe, et al.
The Clinical Investigator|March 1, 1993
HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donorsB O Boehm, P Kühnl, C Löliger, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|August 1, 1993
Recent evaluation of prognostic risk factors in esophageal atresia--a multicenter review of 223 casesA M Rokitansky, V A Kolankaya, S Seidl, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|December 1, 1992
Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endotheliumB Watschinger, W Ulrich, A Vychytil, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|May 1, 1975
Representative HL-A phenotype and haplotype frequencies of the german populationE D Albert, S Scholz, J Bertrams, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis]P Kühnl, M Roggendorf, W Sibrowski, et al.
Digestion|March 20, 2008
True adenomas of the cardia: a case series of 3 patientsM Bajbouj, C von Weyhern, V Becker, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study]S Seidl, P Kühnl, J Beyer, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
Abbott HCV EIA 2nd generation: a new screening assayW Weise, U Bäcker, S Seidl, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)]P Kühnl, M Roggendorf, W Stangel, et al.
AIDS (London, England)|December 1, 1988
A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteinsU Bäcker, A Gathof, J Howe, et al.
The Clinical Investigator|March 1, 1993
HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donorsB O Boehm, P Kühnl, C Löliger, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|August 1, 1993
Recent evaluation of prognostic risk factors in esophageal atresia--a multicenter review of 223 casesA M Rokitansky, V A Kolankaya, S Seidl, et al.
Pageof 16